| 15/01/2025 | STA Pharmaceutical Hong Kong Investment Limited (合全藥業香港投資有限公司) | 1201(L) | -50,000,000(L) | | 314,000,000(L) | 26.16 | | 15/01/2025 | Shanghai SynTheAll Pharmaceutical Co., Ltd. (上海合全藥業股份有限公司) | 1201(L) | -50,000,000(L) | | 314,000,000(L) | 26.16 | | 15/01/2025 | Morgan Stanley | 1704(L) | -43,963,899(L) | | 23,671,573(L)
6,555,872(S)
0(P) | 1.97
0.54
0.00 | | 15/01/2025 | WuXi AppTec Co., Ltd. (無錫藥明康德新藥開發股份有限公司) | 1201(L) | -50,000,000(L) | | 314,000,000(L) | 26.16 | | 15/01/2025 | WuXi AppTec (Shanghai) Co., Ltd. (上海藥明康德新藥開發有限公司) | 1201(L) | -50,000,000(L) | | 314,000,000(L) | 26.16 | | 14/01/2025 | Morgan Stanley | 1305(L) | 146,006(L) | | 66,910,572(L)
5,914,472(S)
0(P) | 5.57
0.49
0.00 | | 13/01/2025 | Morgan Stanley | 1013(L) | +51,331,500(L) | | 66,910,572(L)
5,914,472(S)
0(P) | 5.57
0.49
0.00 | | 12/11/2024 | Shanghai SynTheAll Pharmaceutical Co., Ltd. (上海合全藥業股份有限公司) | 1201(L) | -36,000,000(L) | | 364,000,000(L) | 30.34 | | 12/11/2024 | STA Pharmaceutical Hong Kong Investment Limited (合全藥業香港投資有限公司) | 1201(L) | -36,000,000(L) | | 364,000,000(L) | 30.34 | | 12/11/2024 | WuXi AppTec (Shanghai) Co., Ltd. (上海藥明康德新藥開發有限公司) | 1201(L) | -36,000,000(L) | | 364,000,000(L) | 30.34 | | 12/11/2024 | WuXi AppTec Co., Ltd. (無錫藥明康德新藥開發股份有限公司) | 1201(L) | -36,000,000(L) | | 364,000,000(L) | 30.34 | | | 1 2 |
|
